PHIO PHARMACEUTICALS CORP. Operating Expenses
PHIO PHARMACEUTICALS CORP. (PHIO) reported Operating Expenses of $4.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- PHIO PHARMACEUTICALS CORP. operating expenses for the quarter ending 2026-06-30 was $4.27M, a 84.84% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. operating expenses for the quarter ending 2026-03-31 was $4.17M, a 122.60% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. operating expenses for the quarter ending 2025-12-31 was $2.53M, a 51.37% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. operating expenses for the quarter ending 2025-09-30 was $2.50M, a 57.55% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. operating expenses for fiscal 2025 was $9.22M, a 24.81% increase from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. operating expenses for fiscal 2024 was $7.39M, a 31.75% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. operating expenses for fiscal 2023 was $10.82M, a 5.57% decline from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. operating expenses for fiscal 2022 was $11.46M, a 15.17% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 114 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.27M 10-Q · filed 2026-08-06 | $8.44M 10-Q · filed 2026-08-06 | $10.97M derived: sum of 3 quarters · filed 2026-08-06 | $13.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $4.17M 10-Q · filed 2026-05-07 | $6.70M derived: sum of 2 quarters · filed 2026-05-07 | $9.21M derived: sum of 3 quarters · filed 2026-05-07 | $11.52M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $5.04M derived: sum of 2 quarters · filed 2026-03-05 | $7.35M derived: sum of 3 quarters · filed 2026-08-06 | $9.22M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $2.50M 10-Q · filed 2025-11-13 | $4.81M derived: sum of 2 quarters · filed 2026-08-06 | $6.69M 10-Q · filed 2025-11-13 | $8.36M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.31M 10-Q · filed 2026-08-06 | $4.18M 10-Q · filed 2026-08-06 | $5.86M derived: sum of 3 quarters · filed 2026-08-06 | $7.45M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.87M 10-Q · filed 2026-05-07 | $3.55M derived: sum of 2 quarters · filed 2026-05-07 | $5.14M derived: sum of 3 quarters · filed 2026-05-07 | $7.05M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.26M derived: sum of 2 quarters · filed 2026-03-05 | $5.18M derived: sum of 3 quarters · filed 2026-03-05 | $7.39M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $1.59M 10-Q · filed 2025-11-13 | $3.50M derived: sum of 2 quarters · filed 2025-11-13 | $5.71M 10-Q · filed 2025-11-13 | $7.61M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.91M 10-Q · filed 2025-08-14 | $4.12M 10-Q · filed 2025-08-14 | $6.02M derived: sum of 3 quarters · filed 2025-08-14 | $8.80M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $2.21M 10-Q · filed 2025-05-15 | $4.11M derived: sum of 2 quarters · filed 2025-05-15 | $6.88M derived: sum of 3 quarters · filed 2025-05-15 | $9.43M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.67M derived: sum of 2 quarters · filed 2025-03-31 | $7.22M derived: sum of 3 quarters · filed 2025-03-31 | $10.82M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $2.78M 10-Q · filed 2024-11-14 | $5.32M derived: sum of 2 quarters · filed 2024-11-14 | $8.93M 10-Q · filed 2024-11-14 | $11.65M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.55M 10-Q · filed 2024-08-14 | $6.15M 10-Q · filed 2024-08-14 | $8.88M derived: sum of 3 quarters · filed 2024-08-14 | $12.45M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $3.60M 10-Q · filed 2024-05-09 | $6.33M derived: sum of 2 quarters · filed 2024-05-09 | $9.90M derived: sum of 3 quarters · filed 2024-05-09 | $12.42M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $6.30M derived: sum of 2 quarters · filed 2024-04-01 | $8.82M derived: sum of 3 quarters · filed 2024-04-01 | $11.46M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $3.57M 10-Q · filed 2023-11-09 | $6.09M derived: sum of 2 quarters · filed 2023-11-09 | $8.73M 10-Q · filed 2023-11-09 | $12.18M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $2.52M 10-Q · filed 2023-08-10 | $5.16M 10-Q · filed 2023-08-10 | $8.61M derived: sum of 3 quarters · filed 2023-08-10 | $12.35M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $2.64M 10-Q · filed 2023-05-11 | $6.09M derived: sum of 2 quarters · filed 2023-05-11 | $9.83M derived: sum of 3 quarters · filed 2023-05-11 | $12.51M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $3.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $7.19M derived: sum of 2 quarters · filed 2023-03-22 | $9.87M derived: sum of 3 quarters · filed 2023-03-22 | $13.51M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $3.74M 10-Q · filed 2022-11-10 | $6.42M derived: sum of 2 quarters · filed 2022-11-10 | $10.06M 10-Q · filed 2022-11-10 | $12.52M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.68M 10-Q · filed 2022-08-11 | $6.32M 10-Q · filed 2022-08-11 | $8.78M derived: sum of 3 quarters · filed 2022-08-11 | $11.09M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $3.64M 10-Q · filed 2022-05-12 | $6.10M derived: sum of 2 quarters · filed 2022-05-12 | $8.41M derived: sum of 3 quarters · filed 2022-05-12 | $10.07M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $4.77M derived: sum of 2 quarters · filed 2022-03-22 | $6.44M derived: sum of 3 quarters · filed 2022-03-22 | $8.79M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $2.31M 10-Q · filed 2021-11-10 | $3.98M derived: sum of 2 quarters · filed 2021-11-10 | $6.33M 10-Q · filed 2021-11-10 | $9.00M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $1.67M 10-Q · filed 2021-08-12 | $4.03M 10-Q · filed 2021-08-12 | $6.69M derived: sum of 3 quarters · filed 2021-08-12 | $8.81M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $2.36M 10-Q · filed 2021-05-13 | $5.03M derived: sum of 2 quarters · filed 2021-05-13 | $7.14M derived: sum of 3 quarters · filed 2021-05-13 | $9.20M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $4.78M derived: sum of 2 quarters · filed 2021-03-25 | $6.84M derived: sum of 3 quarters · filed 2021-03-25 | $9.01M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $2.11M 10-Q · filed 2020-11-10 | $4.17M derived: sum of 2 quarters · filed 2020-11-10 | $6.34M 10-Q · filed 2020-11-10 | $8.07M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $2.06M 10-Q · filed 2020-08-12 | $4.23M 10-Q · filed 2020-08-12 | $5.96M derived: sum of 3 quarters · filed 2020-08-12 | $7.51M derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $2.17M 10-Q · filed 2020-05-12 | $3.90M derived: sum of 2 quarters · filed 2020-05-12 | $5.45M derived: sum of 3 quarters · filed 2020-05-12 | $7.41M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $3.28M derived: sum of 2 quarters · filed 2020-03-26 | $5.24M derived: sum of 3 quarters · filed 2020-03-26 | $7.50M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $1.55M 10-Q · filed 2019-11-12 | $3.51M derived: sum of 2 quarters · filed 2019-11-12 | $5.77M 10-Q · filed 2019-11-12 | $7.77M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $1.96M 10-Q · filed 2019-08-12 | $4.22M 10-Q · filed 2019-08-12 | $6.22M derived: sum of 3 quarters · filed 2019-08-12 | $8.70M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $2.26M 10-Q · filed 2019-05-14 | $4.27M derived: sum of 2 quarters · filed 2019-05-14 | $6.74M derived: sum of 3 quarters · filed 2019-05-14 | $9.26M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $4.48M derived: sum of 2 quarters · filed 2019-03-27 | $7.00M derived: sum of 3 quarters · filed 2019-03-27 | $14.08M 10-K · filed 2019-03-27 | ||||
| 2017-09-30 | $2.48M 10-Q · filed 2018-11-14 | $4.99M derived: sum of 2 quarters · filed 2018-11-14 | $12.07M 10-Q · filed 2018-11-14 | $10.45M 10-Q · filed 2017-11-08 | $14.41M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $2.51M 10-Q · filed 2018-08-14 | $9.60M 10-Q · filed 2018-08-14 | $7.97M 10-Q · filed 2017-08-10 | $11.93M derived: sum of 3 quarters · filed 2018-08-14 | $14.15M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $7.08M 10-Q · filed 2018-05-10 | $5.46M 10-Q · filed 2017-05-11 | $9.42M derived: sum of 2 quarters · filed 2018-05-10 | $11.64M derived: sum of 3 quarters · filed 2018-05-10 | $13.86M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $2.34M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | $4.55M derived: sum of 2 quarters · filed 2018-03-26 | $6.78M derived: sum of 3 quarters · filed 2018-03-26 | $9.03M 10-K · filed 2018-03-26 | ||||
| 2016-09-30 | $2.22M 10-Q · filed 2016-11-10 | $4.44M derived: sum of 2 quarters · filed 2018-03-26 | $6.70M 10-Q/A · filed 2018-03-26 | $9.32M derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2016-06-30 | $2.22M 10-Q/A · filed 2018-03-26 | $4.48M 10-Q/A · filed 2018-03-26 | $7.10M derived: sum of 3 quarters · filed 2018-03-26 | $9.61M derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2016-03-31 | $2.25M 10-Q/A · filed 2018-03-26 | $4.88M derived: sum of 2 quarters · filed 2018-03-26 | $7.38M derived: sum of 3 quarters · filed 2018-03-26 | $9.55M derived: sum of 4 quarters · filed 2018-03-26 | ||||
| 2015-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $5.13M derived: sum of 2 quarters · filed 2017-03-30 | $7.29M derived: sum of 3 quarters · filed 2017-03-30 | $10.27M 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $2.50M 10-Q · filed 2016-11-10 | $4.67M derived: sum of 2 quarters · filed 2016-11-10 | $7.65M 10-Q · filed 2016-11-10 | $9.97M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $2.17M 10-Q · filed 2016-08-11 | $5.14M 10-Q · filed 2016-08-11 | $7.46M derived: sum of 3 quarters · filed 2016-08-11 | $9.69M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $2.98M 10-Q · filed 2016-05-12 | $5.30M derived: sum of 2 quarters · filed 2016-05-12 | $7.53M derived: sum of 3 quarters · filed 2016-05-12 | $9.56M derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.54M derived: sum of 2 quarters · filed 2016-03-30 | $6.58M derived: sum of 3 quarters · filed 2016-03-30 | $8.90M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $2.23M 10-Q · filed 2015-11-12 | $4.26M derived: sum of 2 quarters · filed 2015-11-12 | $6.58M 10-Q · filed 2015-11-12 | $9.12M derived: sum of 4 quarters · filed 2015-11-12 | ||||
| 2014-06-30 | $2.03M 10-Q · filed 2015-08-12 | $4.35M 10-Q · filed 2015-08-12 | $6.90M derived: sum of 3 quarters · filed 2015-08-12 | $9.06M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2014-03-31 | $2.32M 10-Q · filed 2015-05-13 | $4.87M derived: sum of 2 quarters · filed 2015-05-13 | $7.03M derived: sum of 3 quarters · filed 2015-05-13 | $9.22M derived: sum of 4 quarters · filed 2015-05-13 | ||||
| 2013-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $4.71M derived: sum of 2 quarters · filed 2015-03-30 | $6.90M derived: sum of 3 quarters · filed 2015-03-30 | $21.35M 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | $2.16M 10-Q · filed 2014-11-13 | $4.35M derived: sum of 2 quarters · filed 2014-11-13 | $18.80M 10-Q · filed 2014-11-13 | $20.55M derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | $2.19M 10-Q · filed 2014-08-14 | $16.64M 10-Q · filed 2014-08-14 | $18.39M derived: sum of 3 quarters · filed 2014-08-14 | $20.14M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $14.45M 10-Q · filed 2014-05-14 | $16.20M derived: sum of 2 quarters · filed 2014-05-14 | $17.95M derived: sum of 3 quarters · filed 2014-05-14 | $25.61M derived: sum of 4 quarters · filed 2014-05-14 | ||||
| 2012-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.50M derived: sum of 2 quarters · filed 2014-03-28 | $11.17M derived: sum of 3 quarters · filed 2014-03-28 | $13.07M 10-K · filed 2014-03-28 | ||||
| 2012-09-30 | $1.75M 10-Q · filed 2013-11-14 | $9.42M derived: sum of 2 quarters · filed 2013-11-14 | $11.32M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | $7.66M 10-Q · filed 2013-08-14 | $9.57M 10-Q · filed 2013-08-14 | $92.52M 10-Q · filed 2012-08-14 | |||||
| 2012-03-31 | $1.91M 10-Q · filed 2013-05-15 | |||||||
| 2011-06-30 | $2.84M 10-Q · filed 2012-08-14 | $8.11M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |